About this trial
The purpose of this study is to evaluate the clinical efficacy and safety of dialectical treatment in the patients with pneumonia after discharge in a prospective cohort study: one is the Traditional Chinese Medicine (TCM) cohort, which has been evaluated and has certain effects; The other is a non traditional Chinese medicine queue.
Eligibility criteria
Qualifiers
Hospitalized patients with a confirmed diagnosis of pneumonia (HAP, CAP).
Age ≥18 years.
Signed informed consent form.
Disqualifiers
Patients with confusion, consciousness disorders, dementia, and various mental illnesses;
Patients with altered mental status, dementia, consciousness disorders, or various psychiatric conditions;
Those who are completely unable to care for themselves or are bedridden long-term; and those currently participating in other clinical drug trials.
Known to be allergic to treatment drugs.
Trial design
Treatments tested in this trial
- TCM
Treatment groups
Locations
Sponsors and collaborators
Henan University of Traditional Chinese Medicine
Lead sponsor
Wuhan No.1 Hospital
Collaborator
Hebei Provincial Hospital of Traditional Chinese Medicine
Collaborator
Shanghai University of Traditional Chinese Medicine
Collaborator
Qingdao Hiser Medical Group
Collaborator
The First Affiliated Hospital of Zhejiang Chinese Medical University
Collaborator
Shaanxi Hospital of Traditional Chinese Medicine
Collaborator